X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse PLETHICO PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PLETHICO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
ADCOCK INGRAM
Jun-14
PLETHICO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs395366-   
Low Rs31264-   
Sales per share (Unadj.) Rs604.4108.9-  
Earnings per share (Unadj.) Rs32.5-27.4-  
Cash flow per share (Unadj.) Rs51.3-22.7-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs473.685.5-  
Shares outstanding (eoy) m34.08168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.42.9 12.2%   
Avg P/E ratio x6.6-11.5 -57.1%  
P/CF ratio (eoy) x4.2-13.9 -30.0%  
Price / Book Value ratio x0.53.7 12.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m7,26253,186 13.7%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m1,5963,338 47.8%   
Avg. sales/employee Rs ThNM4,281.9-  
Avg. wages/employee Rs ThNM777.6-  
Avg. net profit/employee Rs ThNM-1,078.9-  
INCOME DATA
Net Sales Rs m20,59818,382 112.1%  
Other income Rs m386129 300.1%   
Total revenues Rs m20,98418,511 113.4%   
Gross profit Rs m2,818-3,185 -88.5%  
Depreciation Rs m642793 81.0%   
Interest Rs m1,593498 320.0%   
Profit before tax Rs m969-4,348 -22.3%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138272 -50.9%   
Profit after tax Rs m1,107-4,632 -23.9%  
Gross profit margin %13.7-17.3 -78.9%  
Effective tax rate %-14.3-6.2 228.7%   
Net profit margin %5.4-25.2 -21.3%  
BALANCE SHEET DATA
Current assets Rs m18,87713,463 140.2%   
Current liabilities Rs m11,8967,575 157.0%   
Net working cap to sales %33.932.0 105.8%  
Current ratio x1.61.8 89.3%  
Inventory Days Days36111 32.4%  
Debtors Days Days198124 159.6%  
Net fixed assets Rs m9,8617,848 125.6%   
Share capital Rs m34185 399.2%   
"Free" reserves Rs m12,3310-   
Net worth Rs m16,13914,428 111.9%   
Long term debt Rs m4,7065,070 92.8%   
Total assets Rs m33,14627,255 121.6%  
Interest coverage x1.6-7.7 -20.8%   
Debt to equity ratio x0.30.4 83.0%  
Sales to assets ratio x0.60.7 92.1%   
Return on assets %8.1-15.2 -53.7%  
Return on equity %6.9-32.1 -21.4%  
Return on capital %12.3-19.8 -62.0%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Net fx Rs m1,2190-   
CASH FLOW
From Operations Rs m2,4371,569 155.3%  
From Investments Rs m-6,265-482 1,300.4%  
From Financial Activity Rs m2,4904,602 54.1%  
Net Cashflow Rs m-1,3375,689 -23.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.05 Rs / ZAR

Compare PLETHICO PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PLETHICO PHARMA With: JUBILANT LIFE SCIENCES  MERCK LTD  AUROBINDO PHARMA  GSK PHARMA  ORCHID PHARMA LTD  



Today's Market

Sensex Trades Marginally Higher; Yes Bank & Tata Motors Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. Sectoral indices are trading on a positive note with stocks in the realty sector.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

Laurus Labs Ltd (IPO)

Dec 6, 2016

Equitymaster analyses Initial Public Offering (IPO) of Laurus Labs, one of the leading supplier of APIs for ARVs and Hepatitis C.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 5-YR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS